Biomaterial Database

Relapse of staphylococcal endocarditis after clindamycin therapy. 1975

C U Tuazon, and J N Sheagren

A 25-year-old black female heroin addict presented with Staphylococcus aureus endocarditis. Because of a history of penicillin allergy, therapy was gegun with cephalothin (Keflin); lack of clinical response led to the use of clindamycin. Response was excellent. After six weeks of treatment she was discharged well, only to return six days later with recurrent endocarditis. The organism, confirmed by sensitivity and phage typing, was identifcal to that causing the inital episode. This patient illustrates the apparent failure of clindamycin to eradicate a deep-seated intravascular infection with a sensitive organism.

UI	MeSH Term	Description	Entries
D008826	Microbial Sensitivity Tests	Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).	Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D012008	Recurrence	The return of a sign, symptom, or disease after a remission.	Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002981	Clindamycin	An antibacterial agent that is a semisynthetic analog of LINCOMYCIN.	7-Chloro-7-deoxylincomycin,Chlolincocin,Chlorlincocin,Cleocin,Clindamycin Hydrochloride,Clindamycin Monohydrochloride,Clindamycin Monohydrochloride, Monohydrate,Dalacin C,7 Chloro 7 deoxylincomycin,Hydrochloride, Clindamycin,Monohydrate Clindamycin Monohydrochloride,Monohydrochloride, Clindamycin,Monohydrochloride, Monohydrate Clindamycin
D004697	Endocarditis, Bacterial	Inflammation of the ENDOCARDIUM caused by BACTERIA that entered the bloodstream. The strains of bacteria vary with predisposing factors, such as CONGENITAL HEART DEFECTS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; or intravenous drug use.	Bacterial Endocarditides,Bacterial Endocarditis,Endocarditides, Bacterial
D005260	Female		Females
D006556	Heroin Dependence	Strong dependence or addiction, both physiological and emotional, upon HEROIN.	Heroin Abuse,Heroin Addiction,Heroin Smoking,Abuse, Heroin,Addiction, Heroin,Dependence, Heroin,Heroin Smokings,Smoking, Heroin
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328	Adult	A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.	Adults
D000900	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA.	Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013203	Staphylococcal Infections	Infections with bacteria of the genus STAPHYLOCOCCUS.	Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections

Related Publications

C U Tuazon, and J N Sheagren

Clindamycin therapy of Staphylococcus aureus endocarditis. Clinical relapse and development of resistance to clindamycin, lincomycin and erythromycin.

March 1976, The American journal of medicine,

C U Tuazon, and J N Sheagren

Endocarditis treated with clindamycin: relapse and liver dysfunction.

July 1977, Southern medical journal,

C U Tuazon, and J N Sheagren

[Therapy of staphylococcal endocarditis].

August 1977, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,

C U Tuazon, and J N Sheagren

Antibiotic therapy of staphylococcal endocarditis.

September 1979, Annals of internal medicine,

C U Tuazon, and J N Sheagren

Clindamycin therapy of experimental Staphylococcus aureus endocarditis.

April 1982, Antimicrobial agents and chemotherapy,

C U Tuazon, and J N Sheagren

Staphylococcal endocarditis---recommendations for therapy.

January 1998, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,

C U Tuazon, and J N Sheagren

Staphylococcal endocarditis after dental extraction.

August 1986, Lancet (London, England),

C U Tuazon, and J N Sheagren

[Staphylococcal endocarditis after mitral commissurotomy].

January 1972, Grudnaia khirurgiia (Moscow, Russia),

C U Tuazon, and J N Sheagren

Penicillin sensitive nutritionally variant streptococcal endocarditis: relapse after penicillin therapy.

January 1983, The American journal of the medical sciences,

C U Tuazon, and J N Sheagren

Clindamycin, endocarditis, hepatotoxicity.

May 1973, Annals of internal medicine,